Contrast-Induced Nephropathy in Postmenopausal Women Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

Guizhou Ma; Danqing Yu; Zhixiong Cai; Chumin Ni; Ronghe Xu; Bin Lan; Ping Chen; Zhidan Zhu
July 2010
Tohoku Journal of Experimental Medicine;Jul2010, Vol. 221 Issue 3, p211
Academic Journal
Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury induced by exposure to intravascular contrast media. CIN occurs frequently in patients undergoing urgent percutaneous coronary intervention (PCI) and is associated with poor outcomes, making it a major challenge faced by interventional cardiologists. It has been suggested that female sex is a risk factor for development of CIN following PCI. However, no data exist in the literature concerning the risks of postmenopausal women with acute myocardial infarction (AMI) developing CIN after undergoing urgent PCI. To explore the incidence, risk factors and in-hospital outcomes of CIN in this special population, we analyzed 69 postmenopausal women with AMI treated with urgent PCI. CIN was defined as a relative increase of > 25% or an absolute increase of ≥ 0.5 mg/dL in serum creatinine concentration from the baseline value 72 h after exposure to contrast medium. We found 1) the incidence of CIN was 37.68%; 2) patients with CIN had worse in-hospital outcomes, including longer hospital stay and more in-hospital adverse events; and 3) in multivariate logistic analysis, independent risk factors for CIN included a longer menopausal duration and the implantation of an intra-aortic balloon pump (an indirect indicator of hemodynamic instability). These results indicate that CIN is a frequent complication associated with worse in-hospital outcomes in postmenopausal women with AMI who are undergoing urgent PCI, particularly those with longer menopausal duration and hemodynamic instability. It is therefore necessary to pay more attention to preventive strategies for renal protection in this special population.


Related Articles

  • Immediate- and late-hemodynamic coronary effects of tadalafil in men with erectile dysfunction and coronary artery disease. Bellotto, F.; Ruscazio, M.; Bonanni, G.; Montisci, R.; Cutolo, A.; Sarais, C.; Setzu, T.; Borrini, A.; Iliceto, S. // International Journal of Impotence Research;Mar/Apr2008, Vol. 20 Issue 2, p168 

    We investigated whether coronary flow reserve (CFR) can be modified by tadalafil, a long-acting phosphodiesterase 5 (PDE5) inhibitor, in patients with documented coronary artery disease (CAD). CFR was non-invasively evaluated in 12 men with a positive history for erectile dysfunction (ED) and...

  • QT interval in CKD and haemodialysis patients. Di Iorio, Biagio; Bellasi, Antonio // Clinical Kidney Journal;Apr2013, Vol. 6 Issue 2, p137 

    Cardiovascular (CV) disease is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. Although about half of the deaths are due to CV causes, only a minority are directly linked to myocardial infarction and it is estimated that cardiac arrest or cardiac...

  • Autonomic Contribution to Endothelin-1 Increase during Laboratory Anger-Recall Stress in Patients with Coronary Artery Disease. Burg, Matthew M.; Soufer, Aaron; Lampert, Rachel; Collins, Dorothea; Soufer, Robert // Molecular Medicine;May/Jun2011, Vol. 17 Issue 5/6, p495 

    In coronary artery disease (CAD), endothelin-1 (ET-1) is released by activated macrophages and thereby contributes to coronary plaque rupture and triggered cardiac events. The multifactorial regulation of ET-1 includes stimulated release by cytokines and autonomic factors. Laboratory stress...

  • Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.  // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 1, p20 

    Discusses research being done on the effect of levosimendan on coronary hemodynamics in the context of acute myocardial infarction associated with left ventricular dysfunction. Reference to a study by L. De Luca and colleagues which appeared in a 2005 issue of the "American Heart Journal";...

  • Synchronization of 0.1 Hz Oscillations in Heart Rate and Blood Pressure: Application to Treatment of Myocardial Infarction Patients. Prokhorov, M. D.; Kiselev, A. R.; Karavaev, A. S.; Posnenkova, O. M.; Gridnev, V. I.; Ponomarenko, V. I. // World Academy of Science, Engineering & Technology;Apr2011, Issue 52, p367 

    Synchronization between 0.1 Hz oscillations in heart rate and blood pressure is studied and its change during vertical tilt is evaluated in 37 myocardial infarction patients. Two groups of patients are identified with decreased and increased, respectively, synchronization of the studied...

  • Korean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig. Kyu Hee Lim; Chang-Won Kang; Jin-Yong Choi; Jong-Hoon Kim // Korean Journal of Physiology & Pharmacology;Aug2013, Vol. 17 Issue 4, p283 

    This study was designed to evaluate the protective effect of Korean red ginseng (KRG) against ischemia/reperfusion (I/R) injury in isolated guinea pig heart. KRG has been shown to possess various ginsenosides, which are the major components of Panax ginseng. These components are known naturally...

  • The Coronary Collateral Circulation in Man. Seiler, Christian // Current Cardiology Reviews;2007, Vol. 3 Issue 2, p111 

    Well developed coronary collateral arteries in patients with coronary artery disease (CAD) mitigate myocardial infarcts with less ventricular aneurysm formation and improved ventricular function, they reduce future cardiovascular events, and improve survival. Myocardial infarct size is a product...

  • Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Sumida, Arihiro; Horiba, Mitsuru; Ishiguro, Hisaaki; Takenaka, Hiroharu; Ueda, Norihiro; Ooboshi, Hiroaki; Opthof, Tobias; Kadomatsu, Kenji; Kodama, Itsuo // Cardiovascular Research;Apr2010, Vol. 86 Issue 1, p113 

    Aim: We have previously reported that therapy with midkine (MK) has a protective effect in mouse models of myocardial infarction (MI) and ischemia/reperfusion. The underlying mechanism was proved to be anti-apoptosis and prevention of left ventricular (LV) remodelling following angiogenesis....

  • Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Kotlyar, A-A; Vered, Z.; Goldberg, I.; Chouraqui, P.; Nas, D.; Fridman, E.; Chen-Levy, Z.; Fytlovich, S.; Sangiorgi, G.; Spagnoli, L. G.; Orlandi, A.; Savion, N.; Eldar, M.; Scheinowitz, M. // Heart;Dec2001, Vol. 86 Issue 6, p693 

    Background: Insulin-like growth factors (IGF) I and II improve myocardial function after coronary occlusion in different animal models. Objective: To investigate the mechanism of improved myocardial function after administration of IGF-I or IGF-II in acute myocardial infarction. Methods: Female...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics